Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Astellas announces share purchase

Astellas announces share purchase

19th August 2008

Astellas Pharma has announced the acquisition of its treasury stock after it came to a decision on the specific method by which this move would be undertaken

It made this purchase pursuant to article 156 – which is applicable in accordance with paragraph three of article 165 of the Companies Act.

The company bought the shares at the Tokyo Stock Exchange last Friday at a closing price of 4,800 yen (23.52 pounds) per share.

Transactions were made through ToSTNeT03 and not any other trading systems, with the purchase order only being valid at the time designated.

Astellas looked to obtain 5.5 million shares of common stock in the company, with the purchase made in response to sell orders corresponding to the amount of stock planned to be acquired.

Earlier this month, the company’s board of directors resolved to purchase a maximum of ten million shares of common stock in the firm for a maximum price of 50 billion yen.

As of last week, it had acquired 3,868,900 shares for just under 18 billion yen.

Earlier this month, Astellas Pharma announced the launch of Mycamine (micafungin sodium) in the UK through its European subsidiary after the compound was granted marketing authorisation by the European Commission.

We currently have 5 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.